Pharmacokinetic aspects of the clinically used proteasome inhibitor drugs and efforts toward nanoparticulate delivery systems Article

Kwon, Seungbin, Kim, Kyung Bo, Yeo, Yoon et al. (2021). Pharmacokinetic aspects of the clinically used proteasome inhibitor drugs and efforts toward nanoparticulate delivery systems . 51(4), 483-502. 10.1007/s40005-021-00532-0

International Collaboration

cited authors

  • Kwon, Seungbin; Kim, Kyung Bo; Yeo, Yoon; Lee, Wooin

sustainable development goals

authors

publication date

  • July 1, 2021

keywords

  • ADVANCED SOLID TUMORS
  • ANTITUMOR-ACTIVITY
  • BORTEZOMIB
  • Bortezomib
  • CANCER
  • CARFILZOMIB
  • Carfilzomib
  • EFFICACY
  • IXAZOMIB
  • Life Sciences & Biomedicine
  • Nanoparticulate drug delivery
  • OPEN-LABEL
  • Pharmacokinetics
  • Pharmacology & Pharmacy
  • Proteasome inhibitors
  • RELAPSED MULTIPLE-MYELOMA
  • SINGLE-ARM
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • SPRINGERNATURE

start page

  • 483

end page

  • 502

volume

  • 51

issue

  • 4